Lantheus Holdings (LNTH) Return on Invested Capital (2015 - 2026)
Lantheus Holdings (LNTH) posted quarterly Return on Invested Capital of 0.88% for Q1 2026, up 87.0% year-over-year from 0.47% in Q1 2025, and down 7.72% quarter-over-quarter from 0.95% in Q4 2025.
Lantheus Holdings (LNTH) Return on Invested Capital (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Return on Invested Capital for 12 consecutive years, with 0.88% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Invested Capital rose 87.0% year-over-year to 0.88%; the TTM figure through Mar 2026 stood at 0.88% (up 87.0% YoY), while the FY2025 annual figure was 3.65%, up 10105.0% from the prior year.
- Return on Invested Capital declined to 0.88% in Q1 2026 per LNTH's latest filing, from 0.95% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 1.49% in Q1 2024 and bottomed at 0.15% in Q4 2024.
- Historically, Return on Invested Capital has averaged 0.27% across 5 years, with a median of 0.01% in 2025.
- Annual changes were most pronounced in 2024 — Return on Invested Capital soared 149 bps — and 2025, when it slumped 148 bps.
- Lantheus Holdings' Return on Invested Capital stood at 0.0% in 2022, then soared by 1334 bps to 0.06% in 2023, then sank by 377 bps to 0.15% in 2024, then jumped by 719 bps to 0.95% in 2025, then slipped by 8 bps to 0.88% in 2026.
- Business Quant data shows LNTH's Return on Invested Capital at 0.88% in Q1 2026, 0.95% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 0.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.73% |
| Mar 31, 2026 | 0.88% |
| Dec 31, 2025 | 0.95% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | -0.15% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 1.22% |
| Mar 31, 2024 | 1.49% |
| Dec 31, 2023 | 0.06% |
| Sep 30, 2023 | 0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |